Developing countries

Due to the difficulty in accessing drugs from brand-name pharmaceutical companies, most patients in developing nations are heavily relying on less-expensive generic drugs.

One inhibiting issue is that of patenting and intellectual property protection. The World Trade Organization’s law stipulates that patents should last for 20 years from the registration date. This presumably will provide the